NMN IV vs NAD⁺ IV: A Comparative Overview in Cognition, Metabolism, Aging, and Performance
Clinical Takeaways Cognition NAD⁺ IV therapy has shown a short-term cognitive performance boost in early trials, whereas NMN (as a NAD⁺ precursor)
Dripdok is currently undergoing its routine compliance and regulatory audits. These audits are conducted in accordance with regulatory requirements and, unfortunately, may occur without advance notice.
We expect to complete this process and resume normal scheduling at the beginning of Q4.
During this temporary period, services and scheduling are paused. Due to circumstances beyond our control and this regulatory force majeure period, refunds cannot be issued while operations are temporarily suspended. Existing bookings will be addressed and rescheduled as soon as we are cleared to resume.
We sincerely appreciate your patience, understanding, and continued trust in Dripdok. We look forward to welcoming you back very soon.
Dripdok
Your health. Our priority.